Results 21 to 30 of about 30,918 (200)
Open Medicine, 2022 Non-small cell lung cancer (NSCLC) is a malignant tumor. Serum exosomal miR-27b is related to tumor diagnosis. We explored the roles of serum exosomal miR-27b in NSCLC. NSCLC patients were assigned to NSCLC-early/terminal groups, with healthy subjects as
Cao Xiying +4 more
doaj +1 more source
CLINICAL SIGNIFICANCE OF BIOMARKERS IN OVARIAN CANCER, PROSTATE CANCER, COLORECTAL CANCER
Исследования и практика в медицине, 2016 The review is devoted to modern notions about serum tumor markers and their place in oncology: using for differential diagnosis, in prognosis of course of tumor process, during follow-up, for preclinical detection of disease recurrences, as well as in ...
N. V. Marshutina +3 more
doaj +1 more source
Prevalence of K-RAS mutations and CA125 tumor marker in patients with ovarian carcinoma
Caspian Journal of Internal Medicine, 2020 Background: Ovarian carcinoma is one of the leading causes of cancer-related death among females. K-ras codon 12 mutations are commonly occurring mutations in different types of cancers and leads to resistance against anti-EGFR therapeutics.
Nazanin Bagherlou +4 more
doaj
Survivin and VEGF as novel biomarkers in diagnosis of endometriosis [PDF]
Journal of Medical Biochemistry, 2016 Background: The aim of this study was to investigate the role of peripheral blood markers as additional diagnostic tools to transvaginal ultrasound (TVU) findings in the diagnosis of endometriosis.
Aćimović Milena +6 more
doaj
Prognostic value of glycoprotein CA125 and their time-line changes in decompensated heart failure
Spanish Journal of Medicine, 2021 Introduction and objectives: Glycoprotein carbohydrate antigen 125 (CA125) has been proposed as a new biomarker in heart failure (HF). Its potential prognostic role in chronic (CHF) and acute HF (AHF) is still underrecognized.
Claudia Josa-Laorden +5 more
doaj +1 more source
Open Medicine, 2016 To evaluate the value of individual and combined measurement of human epididymis protein 4 (HE4) and cancer antigen 125 (CA-125) in the diagnosis of ovarian cancer.
Zheng Li-e, Qu Jun-ying, He Fei
doaj +1 more source
Therapeutics and Clinical Risk Management, 2020 Xuanxuan Jing,1,* Chen Li,1,2,* Jintang Sun,1 Jin Peng,3 Yu Dou,4 Xiaofei Xu,3 Chao Ma,1 Zhaogang Dong,5 Yanguo Liu,6 Hui Zhang,3 Qianqian Shao,1 Hui Zhang,7 Lijie Wang,3 Yun Zhang,1 Xun Qu1 1Institute of Basic Medical Sciences, Key Laboratory of ...
Jing X +14 more
doaj
The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity
Diagnostics, 2022 Lung cancer is the second most commonly diagnosed cancer in the world. In terms of the diagnosis of lung cancer, combination carcinoembryonic antigen (CEA) and cancer antigen 125 (CA125) detection had higher sensitivity, specificity, and diagnostic odds ...
Hebatallah M. Saad +14 more
doaj +1 more source
CA125: Holy Grail or a Poisoned Chalice [PDF]
Nephron Clinical Practice, 2005 The history of (and perhaps the lessons to be learned from) peritoneal CA125 investigation presents no better example of the diffi culties in assigning the status of a ‘marker’ predictive of membrane dysfunction to factors measured in dialysis effl uent. In 1995, Visser et al. [3] were the fi rst to suggest that CA125 could be used as ‘a bulk marker of
Nicholas, Topley +2 more
openaire +2 more sources
Analyzing the Role of CA125 in the Care of Patients with Epithelial Ovarian Cancer [PDF]
Batna Journal of Medical SciencesBackground: Ovarian cancer is the most lethal gynecological malignancy, often diagnosed at advanced stages due to asymptomatic presentation. The CA125 tumor marker plays a crucial role in the diagnosis and management of this disease.
Dalal ZERROUK +6 more
doaj +1 more source